1. Executive Summary
2. Research Methodology
3. Assisted Reproductive Technology: Introduction
3.1 Infertility
3.1.1 Causes of Infertility
3.1.2 Infertility Treatments
3.2 Assisted Reproductive Technology (ART)
3.2.1 IVF
3.2.2 Assisted Insemination
3.2.3 Third Party Assisted ART
3.2.4 Assisted Reproductive Treatment (ART) Procedure
4. Assisted Reproductive Technology (ART) Market Analysis
4.1 Market Sizing
4.2 Market Share Analysis
4.2.1 Market Share by Technology
4.2.2 Market Share by Procedure
4.2.3 Market Share by Region
5. Assisted Reproductive Technology (ART) Market Segmentation
5.1 In Vitro Fertilization
5.1.1 Overview
5.1.2 IVF Procedure
5.1.3 Market Sizing (Actual & Forecasted)
5.1.4 Market Share by End-User
5.1.5 Market Penetration by Nations
5.2 Artificial Insemination Market
5.2.1 Overview
5.2.2 Artificial Insemination Procedure
5.2.3 Market Sizing (Actual & Forecasted)
5.2.4 Market Share by Procedure
5.2.5 Market Share by Region
5.3 Third-party assisted ART
5.3.1 Overview
6. Assisted Reproductive Technology (ART) Regional Analysis
6.1 Americas
6.1.1 Market Sizing (Actual & Forecasted)
6.1.2 The US
6.2 Asia Pacific
6.2.1 Market Sizing (Actual & Forecasted)
6.3 Europe Middle East & Africa (EMEA)
6.3.1 Market Sizing (Actual & Forecasted)
7. Assisted Reproductive Technology (ART) Market Dynamics
7.1 Industry Trends & Development
7.1.1 Strategic Alliances
7.1.2 Technological Advancement
7.2 Growth Drivers
7.2.1 Prevalence of Infertility
7.2.2 Advanced Maternal Age
7.2.3 High Obesity Rates
7.2.4 Rising Level of Tobacco & Alcohol Consumption
7.2.5 Low Awareness of Fertility Problems
7.2.6 Favorable Reimbursements
7.3 Challenges
7.3.1 Stringent Regulations
7.3.2 High Treatment Cost
8. Competitive Landscape
9. Company Profiles
9.1 Merck & Co., Inc.
9.2 CooperSurgical, Inc.
9.3 Irvine Scientific Sales Company, Inc.
9.4 Vitrolife AB
9.5 Hamilton Thorne, Inc.